SERPINE1 and lung carcinoma: These findings suggest that pharmacologic inhibition of PAI-1 limits drug resistance, perhaps by suppressing the myofibroblastic characteristics of CAFs, and that the PAI-1 functional blockade may be one approach to enhance the efficacy of cisplatin-based chemotherapy in lung cancer cells [192].